by Admin Neo Lumina | Aug 28, 2023 | Press Release
NeoLumina Bioscience Advancing Development of Proprietary Psychedelic-based Therapeutic Medicines Funding activity initiated to advance lead psilocybin-based product candidate into human studies VANCOUVER, BC (August 30, 2023) – NeoLumina Bioscience Inc. (“NeoLumina”...
by Admin Neo Lumina | Aug 28, 2023 | News
Psychedelics Research and Psilocybin Therapy The Johns Hopkins Center for Psychedelic and Consciousness Research is leading the way in exploring innovative treatments using psilocybin. The molecular structure of psilocybin, a naturally occurring psychedelic compound...
by Admin Neo Lumina | Aug 28, 2023 | News
Psychedelic Treatment for Eating Disorders Unlike most other mental health disorders that can be treated successfully by medication, eating disorders have not been found to be as responsive to traditional psychiatric medicines. Anorexia nervosa has one of the highest...
